Clover Health Investments, Corp.
CLOV
$3.60
$0.010.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 62.88% | 46.93% | 48.53% | 34.27% | 33.71% |
| Total Other Revenue | -7.83% | -70.79% | 98.91% | 22.55% | 14.62% |
| Total Revenue | 62.05% | 44.74% | 49.81% | 34.07% | 33.45% |
| Cost of Revenue | 66.83% | 70.13% | 69.54% | 52.20% | 33.29% |
| Gross Profit | 46.52% | -20.99% | -10.88% | -7.68% | 33.95% |
| SG&A Expenses | 20.05% | 7.03% | 7.71% | 9.88% | 5.69% |
| Depreciation & Amortization | 10.52% | 22.09% | 19.76% | 19.39% | 46.54% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 55.70% | 49.84% | 52.87% | 40.04% | 25.55% |
| Operating Income | 2,245.53% | -129.95% | -161.47% | -237.85% | 94.42% |
| Income Before Tax | 2,245.53% | -129.60% | -177.48% | -247.53% | 94.50% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2,245.53% | -129.60% | -177.48% | -247.53% | 94.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2,245.53% | -123.25% | -166.27% | -242.79% | 93.35% |
| EBIT | 2,245.53% | -129.95% | -161.47% | -237.85% | 94.42% |
| EBITDA | 3,546.66% | -131.70% | -166.82% | -227.22% | 96.41% |
| EPS Basic | 2,111.54% | -112.47% | -154.01% | -236.84% | 93.40% |
| Normalized Basic EPS | 2,143.75% | -118.32% | -149.58% | -232.65% | 94.54% |
| EPS Diluted | 2,023.08% | -112.47% | -154.01% | -298.10% | 93.40% |
| Normalized Diluted EPS | 2,143.75% | -118.32% | -149.58% | -235.42% | 94.54% |
| Average Basic Shares Outstanding | 5.06% | 5.16% | 4.60% | 4.42% | 2.20% |
| Average Diluted Shares Outstanding | 5.06% | 5.16% | 4.60% | 2.80% | 2.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |